News

Biotronik announced that the first device patients to undergo full-body magnetic resonance imaging (MRI) scans in the United States have been implanted with the Biotronik DX System. 

FDA Biotronik ProMRI ICD Full-body Scans DX Technology

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved a significant expansion of its ongoing ProMRI trial. 

May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-defibrillators (ICDs) can safely extend...

ICD Implants Heart Rhythm Society Clinical Study Insurance Male

A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance disparities in implantable...

May 19, 2014 — St. Jude Medical announced that data presented during a late-breaking clinical trial session at the 2014 annual scientific sessions of the Heart Rhythm Society (HRS) found an...

May 13, 2014 — The Heart Rhythm Society (HRS), American College of Cardiology (ACC) and American Heart Association (AHA) released Expert Consensus Statement on the Use of Implantable...

Boston Scientific Corp. ICD HRS 35th Annual Scientific Sessions SIMPLE Trial

A Boston Scientific Corp. study demonstrated that outcomes for patients with the company's transvenous implantable cardioverter defibrillators (ICD) who received routine defibrillation testing (DT...

May 12, 2014 — Patients using the Boston Scientific Latitude remote patient management system with wireless telemetry demonstrated significantly lower mortality and fewer hospitalizations...

May 6, 2014 — Medtronic announced the first U.S. implant of the Evera MRI SureScan implantable cardioverter-defibrillator (ICD) system, following U.S. Food and Drug Administration (FDA)...

April 28, 2014 — Boston Scientific Corp. has conducted the first implant in the clinical trial of the next-generation Acuity X4 left ventricular (LV) pacing leads and Reliance 4-Front implantable...

April 24, 2014 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for its latest generation of defibrillators and heart failure devices. The newly approved...

ICD Heart Failure Treatments VAD California Boston Scientific

Three weeks after delivering her first child, Amanda began to suffer from extreme fatigue, headaches, a tight chest and stomach pain. An initial diagnosis of pneumonia changed for the worse:...

Biotronik Iforia ICD ProMRI Clinical Trail U.S.

Biotronik announced that the first patients across the United States have received implants of the new Iforia implantable cardioverter-defibrillators (ICDs).

April 11, 2014 — Medtronic announced CE mark and European launch of the Evera MRI SureScan implantable cardioverter-defibrillator (ICD) system, the first and only ICD system approved for...

April 11, 2014 — Boston Scientific Corp. has expanded the launch of its S-ICD (subcutaneous implantable cardioverter-defibrillator) system into parts of Asia. The first implant of the S-ICD...

Cardiologists at Arnold Palmer Hospital for Children performed Florida’s first pediatric implant of a new device to prevent sudden cardiac arrest.

ICD, MADIT-CRT trial, long-term followup, ACC.14

Patients in mild heart failure who receive a cardiac resynchronization therapy defibrillator (CRT-D) device may live longer than those implanted with a traditional implantable...

I had become accustomed to making the necessary tradeoffs when choosing the appropriate defibrillator for my patients and until recently thought that these choices were ones that I would always...

St. Jude Medical Optisure Defibrillation Lead

St. Jude Medical Inc. announced the global launch of the Optisure defibrillation lead.

defibrillator, heart study

Medtronic, Inc. announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients in developing countries at high risk for sudden...